Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

32 insider filings · Latest: Jul 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 26, 2024Sep 26 8:05 PMHELEN TORLEY
Proposed Sale
10,000$56.10$561.0K

View →

Sep 25, 2024Sep 25 8:00 PMHELEN TORLEY
Proposed Sale
10,000$56.34$563.4K

View →

Sep 24, 2024Sep 24 8:05 PMHELEN TORLEY
Proposed Sale
10,000$58.21$582.1K

View →

Sep 18, 2024Sep 18 8:01 PMMICHAEL LABARRE
Proposed Sale
10,000$62.03$620.3K

View →

Sep 17, 2024Sep 17 8:03 PMMICHAEL LABARRE
Proposed Sale
10,000$62.88$628.8K

View →

Sep 12, 2024Sep 12 8:12 PMHELEN TORLEY
Proposed Sale
10,000$59.20$592.0K

View →

Sep 11, 2024Sep 11 8:05 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

Sep 10, 2024Sep 10 8:16 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 1, 2026Apr 2 10:28 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07131,923(D)

View →

Mar 10, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
1,546$33.5167,678(D)

View →

Mar 9, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
20,000$33.5169,224(D)

View →

Mar 4, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07151,923(D)

View →

Mar 3, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07161,923(D)

View →

Mar 2, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07181,923(D)

View →

Feb 20, 2026Feb 24 11:19 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
2,666$0.007,998(D)

View →

Feb 23, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
7,011$0.0014,022(D)

View →

Feb 20, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,688$0.0036,357(D)

View →

Feb 20, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
22,436$0.0044,872(D)

View →

Feb 20, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
16,757$0.0050,270(D)

View →

Feb 16, 2026Feb 17 11:53 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
16,812$0.000(D)

View →

Feb 16, 2026Feb 17 11:52 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
23,773$0.000(D)

View →

Feb 16, 2026Feb 17 11:51 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
89,055$0.000(D)

View →

Feb 9, 2026Feb 12 2:21 AMCortney CaudillSVP, CHIEF OPERATING OFFICER
Grant/Award
44,248$80.4814,751(D)

View →

Feb 9, 2026Feb 12 2:20 AMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Grant/Award
78,087$80.4829,502(D)

View →

Feb 9, 2026Feb 12 2:20 AMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Grant/Award
42,117$0.0029,502(D)

View →

Feb 9, 2026Feb 12 1:56 AMHelen TorleyDirector, PRESIDENT AND CEO
Grant/Award
241,366$80.4892,714(D)

View →